Target intelligence / Profile preview

Pseudogene similar to part of postmeiotic segregation increased 2-like 1 (PMS2L1)

Target
PMS2L1
Molecular classification
Other (Pseudogene)
01

Overview

PMS2L1 (ENSG00000250778) is a pseudogene with sequence homology to the PMS2 gene, which is a member of the DNA mismatch repair family[1]. Pseudogenes are defined as incomplete or nonfunctional copies of genes, usually lacking the ability to encode functional proteins due to disruptions in their sequence or loss of essential regulatory elements[1]. While the functional PMS2 gene is important for repairing DNA mismatches and is associated with Lynch syndrome when mutated, PMS2L1 and related pseudogenes do not participate in these biological pathways. The existence of PMS2 pseudogenes, including PMS2L1, can complicate genetic analyses and diagnostic testing for Lynch syndrome, as they may be mistaken for functional gene variants, leading to false positive or negative results[1][3]. There is no evidence that PMS2L1 is a therapeutic target, disease biomarker, or has any safety concerns, and it should not be considered a receptor, enzyme, or clinically actionable gene. Based on current knowledge and genomic resources, ENSG00000250778 (PMS2L1) is not a drug target, not a functional protein, and not directly implicated in disease—its main relevance is in complicating genetic analyses of the PMS2 gene because of sequence homology and the potential for analytical confusion[1][3].

Other names
PMS2L1PMS2 pseudogenePMS2-like 1
02

Mechanism of action

None

03

Biological functions

None (pseudogenes generally do not encode functional proteins)
04

Disease associations

None (does not itself play a known disease role)

Beyond the preview

Go deeper on Pseudogene similar to part of postmeiotic segregation increased 2-like 1 (PMS2L1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pseudogene similar to part of postmeiotic segregation increased 2-like 1 (PMS2L1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call